Sign In
Buy DGX
$193.67
+0.510 (+0.264%)
At Close: Jun 03, 2026
Athena Diagnostics Improves Ataxia Movement Disorder Testing with Novel Long-Read Gene Sequencing
08:52am, Tuesday, 29'th Jul 2025
New test utilizes technology based on PacBio's PureTarget sequencing method to uncover genetic causes of disease BOSTON , July 29, 2025 /PRNewswire/ -- Athena Diagnostics, the specialty neurology bus
Why Quest Diagnostics (DGX) is a Top Growth Stock for the Long-Term
10:46am, Monday, 28'th Jul 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Quest Diagnostics Raises 2025 Guidance
05:02pm, Tuesday, 22'nd Jul 2025
Diagnostic testing and information services provider Quest Diagnostics (DGX 7.04%) reported fiscal 2025 second-quarter results on Tuesday, July 22, that topped analysts' consensus expectations. Q2 rev
Quest Diagnostics Boosts Its 2025 Outlook
02:19pm, Tuesday, 22'nd Jul 2025
Quest Diagnostics (DGX 7.16%) reported its second-quarter 2025 results on July 22, achieving consolidated revenue of $2.76 billion (up 15.2% year over year), organic revenue growth of 5.2%, while adju
Quest Diagnostics Raises Outlook, But Warns Of Tariff And Medicare Act Risks
01:10pm, Tuesday, 22'nd Jul 2025
Quest Diagnostics Inc. DGX delivered a robust second quarter in 2025, exceeding analyst expectations with strong sales and earnings growth, prompting an upward revision to its full-year guidance.
Quest Diagnostics Incorporated (DGX) Q2 2025 Earnings Call Transcript
12:22pm, Tuesday, 22'nd Jul 2025
Quest Diagnostics Incorporated (NYSE:DGX ) Q2 2025 Earnings Conference Call July 22, 2025 8:30 AM ET Company Participants James E. Davis - Chairman, CEO & President Sam A.
Quest Diagnostics Beats Q2 Earnings & Revenue Estimates, Stock Rises
09:40am, Tuesday, 22'nd Jul 2025
DGX tops Q2 estimates with 15.2% revenue growth and a strong EPS beat, lifting the stock 3.2% in pre-market trading.
Quest Diagnostics (DGX) Beats Q2 Earnings and Revenue Estimates
08:56am, Tuesday, 22'nd Jul 2025
Quest Diagnostics (DGX) came out with quarterly earnings of $2.62 per share, beating the Zacks Consensus Estimate of $2.57 per share. This compares to earnings of $2.35 per share a year ago.
Quest Diagnostics raises annual forecasts on strong diagnostic testing demand
07:17am, Tuesday, 22'nd Jul 2025
Laboratory operator Quest Diagnostics raised its 2025 profit and revenue forecasts on Tuesday, banking on robust demand for its diagnostic tests, sending the company's shares up over 3% in premarket t
Quest Diagnostics Reports Second Quarter 2025 Financial Results; Raises Guidance for Full Year 2025
06:47am, Tuesday, 22'nd Jul 2025
Second quarter revenues of $2.76 billion, up 15.2% from 2024 Second quarter reported diluted earnings per share ("EPS") of $2.47, up 21.7% from 2024; and adjusted diluted EPS of $2.62, up 11.5% from 2
Should You Buy Quest Diagnostics Ahead of Earnings?
09:41am, Monday, 21'st Jul 2025
DGX is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
DGX Q2 Earnings Preview: Will Advanced Diagnostics Lead Performance?
09:05am, Monday, 21'st Jul 2025
Quest Diagnostics' Q2 results may get a lift from Advanced Diagnostics, new health plan deals and recent acquisitions.
Will Quest Diagnostics (DGX) Beat Estimates Again in Its Next Earnings Report?
01:11pm, Thursday, 17'th Jul 2025
Quest Diagnostics (DGX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Quest Diagnostics (DGX) is a Top-Ranked Value Stock: Should You Buy?
10:41am, Tuesday, 15'th Jul 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Quest Diagnostics Introduces Testing for Oropouche Virus
07:57am, Tuesday, 15'th Jul 2025
Diagnostic testing for emerging infectious disease associated with severe neurological affects SECAUCUS, N.J. , July 15, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic inf
